Recent Comments

Comment RSS

Angioplasty News and Research RSS Feed - Angioplasty News and Research

In angioplasty procedures, a balloon is fed through a catheter and used to prop open an artery that has become narrowed or blocked. In cases where stenting is appropriate, a stent mounted on a balloon is inserted and inflation of the balloon expands the stent against the blocked artery wall to hold the vessel open. The balloon is then deflated and the catheter is withdrawn. Stent treatment of arteries holds them open and improves blood flow to the heart. In cases where post-dilatation is needed, a high-pressure balloon is inflated inside a stent to help better place the stent against the vessel wall. More than two million balloon angioplasty procedures are performed per year globally, including nearly 1.3 million procedures annually in the United States.

Cardio Vascular Medical Device to initiate patent applications for its "steerable guidewire" in Europe

21. November 2009 00:16
Cardio Vascular Medical Device Corp., a leading developer of advanced cardiovascular surgery technology, today announced that the company's Board of Directors has decided to initiate patent applications in Europe, Canada and the Far East for its proprietary next-generation "steerable guidewire" applicable for all angioplasty (PCTA) procedures. [More]

Posted in: Device / Technology News | Medical Procedure News | Medical Patent News

Tags:

Cardiovascular Systems commences patient enrollment in CALCIUM 360° clinical trial

19. November 2009 08:45
Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI’s Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg. [More]

Updated clinical guidelines on Effient treatment for ACS patients

19. November 2009 06:53
Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention (PCI) and a second one for patients with ST elevation myocardial infarction (STEMI), or severe heart attack. [More]

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

19. November 2009 00:47
The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. [More]

Drug interaction between clopidogrel and omeprazole: New safety information

18. November 2009 06:08
Today the FDA notified healthcare professionals of new safety information concerning a drug interaction between clopidogrel, an anti-clotting medication, and omeprazole, a proton pump inhibitor (PPI) used to reduce stomach acid. [More]

Posted in: Pharmaceutical News

Tags: , ,

Transplanting people's own stem cells into heart muscle lessens pain and improves ability to walk

18. November 2009 01:17
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. [More]

Posted in: Medical Procedure News | Medical Condition News

Tags: , , , , , ,

Drug therapy offers substantial cost savings than angioplasty

18. November 2009 00:43
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. [More]

New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI

17. November 2009 04:22
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Medical Procedure News | Medical Condition News | Pharmaceutical News

Tags: , , , ,

Incidence of stroke related to coronary angioplasty remain steady over a 15-year period: Mayo Clinic study

17. November 2009 03:39
Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty (http://www.mayoclinic.org/heart-catheterization/types.html) remained steady over a 15-year period. Researchers say this is good news because physicians now are performing the artery-opening procedure on older patients who are sicker and need more complicated treatment. [More]

Posted in: Medical Condition News

Tags: , , , ,

Platelet function tests predict heart attacks in patients pre-treated with two anti-clotting medications before coronary stenting

16. November 2009 08:35
Three platelet function tests all identified heart patients who will have blood cells that remain sticky, increasing heart attack risk, despite being pre-treated with two anti-clotting medications before coronary stenting, researchers reported at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , , , , ,

Transcendental Meditation lowers rates of heart attack, stroke, and death

16. November 2009 06:38
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009. [More]

New reversible blood thinner for angioplasty patients not superior over placebo

16. November 2009 04:30
A new reversible blood thinner for angioplasty patients wasn't superior over placebo for its primary combined endpoint of heart attack, all-cause mortality and need for revascularization, but it reduced mortality and in-stent blood clots, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Drug Trial News

Tags: , , , , , , ,

New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients

16. November 2009 04:15
Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , ,

Resources to help understand stroke and carotid artery disease

12. November 2009 04:15
The Society of Interventional Radiology offers numerous resources-including publications and the first-ever Catheter Lysis of Thromboembolic Stroke (CLOTS) course-for interventional radiologists, neuroradiologists, neurointerventionists, body interventionalists, and IR and INR fellows to aid in the understanding of stroke and carotid artery disease. [More]

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

12. November 2009 02:05
Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.